Drug stocks feel the heat
14335
Drug stocks took another hit Friday, a day after a veteran Food and Drug Administration researcher said that five drugs currently on the market needed closer scrutiny for possible safety risks.
278626
The company reports mediocre earnings as investors remain nervous about the drug sector.
473820
As far as stock hits go, this ranks up there as one of the worst. Merck &amp; Co. lost more than $26.6 billion in value yesterday - yes, that&#39;s billion with ab - after the pharmaceutical giant
524656
The cardiovascular risk boogeyman is everywhere. First it struck Merck&#39;s (NYSE: MRK) Vioxx. Then Pfizer&#39;s (NYSE: PFE) Celebrex.
87694
FDA clearance sends stock skyrocketing.
625983
As earnings season arrives, negativity reaches a fever pitch. But the bull market still breathes.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
65084
NEW YORK, Feb. 26 -- Shares of United Therapeutics traded heavily Monday as the market reacted to scientific data affecting the Silver Spring drugmaker's lead product, Remodulin.
276483
Mumbai/Hyderabad: Another week came to a close, but not on a happy note for a clutch of Indian drug companies which felt the heat for different reasons.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
403607
THE pharmaceutical industry was reeling last night, as AstraZeneca and Pfizer put key drug development programmes on hold and Eli Lilly issued a warning on one of its best selling medicines.
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
738382
The drug maker is poised to speed past its rivals.
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
376612
US STOCKS were knocked lower yesterday as investors worried that rising prices for oil and commodities would dent corporate profits, while drug shares fell on possible stricter scrutiny from regulators.
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.
630594
Wall Street stocks were becalmed at midday on Wednesday as cautious investors paused for breath after a tumultuous week.